Related Experiment Video
Updated: May 23, 2025

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development
Published on: January 26, 2013
The asymmetric expression of HSPA2 in blastomeres governs the first embryonic cell-fate decision
Jiayin Gao1,2,3,4,5,6,7,8, Jiawei Wang1,2,3,4,5,6,7,8, Shiyu Liu1,2,3,4,5,6,7,8
1Institute of Women, Children and Reproductive Health, Shandong University, Jinan, China.
Abstract:
The first cell-fate decision is the process by which cells of an embryo take on distinct lineage identities for the first time, thus representing the beginning of developmental patterning. Here, we demonstrate that the molecular chaperone heat shock protein A2 (HSPA2), a member of the 70 kDa heat shock protein (HSP70) family, is asymmetrically expressed in the late 2-cell stage of mouse embryos. The knockdown of Hspa2 in one of the 2-cell blastomeres prevented its progeny predominantly towards the inner cell mass (ICM) fate. In contrast, the overexpression of Hspa2 in one of the 2-cell blastomeres did not induce the blastomere to differentiate towards the ICM fate. Furthermore, we demonstrated that HSPA2 interacted with CARM1 and its levels correlated with ICM-associated genes. Collectively, our results identify HSPA2 as a critical early regulator of the first cell-fate decision in mammalian 2-cell embryos.
Related Concept Videos
Cleavage and Blastulation
Zygotic Development And Stem Cell Formation
Multipotency of Hematopoietic Stem Cells
Hematopoiesis
Determination
Source And Potency Of Stem Cells

